Subretinal Delivery of RGX-314 for Neovascular AMD: End of Study Phase I/IIa Results

Related

• 

  Surgical Case Conference Zofia Michalewska

  Zofia Anna Nawrocka (vel Michalewska), MD, PhD

  Annual Meeting Talks

  2019

• 

  Wieland-Khanani Port Delivery System

  Mark R. Wieland, MD

  Arshad M. Khanani, MD, MA, FASRS

  Updates from the Field

• 

  Early Fluid-Free Status & Long-Term BCVA Outcomes With Anti-VEGF Treatment in nAMD: Post Hoc Analysis of Pooled Data From HAWK & HARRIER Studies

  Chirag D. Jhaveri, MD, FASRS

  On Demand Cases, Courses, and Papers

  2020